论文部分内容阅读
目的了解本院抗高血压药应用现状及其剂型改变趋势。方法对2006—2009年抗高血压药销售金额、剂型等进行统计分析。结果 2006—2009年抗高血压药销售总金额分别为1 611 625.00元、2 340 422.92元、2 783 096.25元、3 105 116.65元,逐年上升;用量最大的药物为氨氯地平片;不同类型药物中,钙通道阻滞剂类销售金额最大;药物种类从2006年25种增至2009年32种;2006-2009年缓控释制剂销售额占总额的比例分别为14.24%、20.91%、21.45%、23.03%,也呈逐年上升。结论钙通道阻滞剂、血管紧张素Ⅱ受体阻滞剂类药物为本院抗高血压的主流药物;药物品种不断增加,缓控释制剂在临床应用中逐渐受到欢迎。
Objective To understand the current status of antihypertensives in our hospital and the changing trend of their dosage forms. Methods The amount of antihypertensive drugs sold in 2006-2009, dosage forms and other statistical analysis. Results The total sales of antihypertensives from 2006 to 2009 were respectively 1 611 625.00 yuan, 2 340 422.92 yuan, 2 783 096.25 yuan and 3 105 116.65 yuan, increasing year by year. The largest amount of drugs were amlodipine tablets. Different types of drugs , The sales amount of calcium channel blockers was the largest; the types of drugs increased from 25 in 2006 to 32 in 2009; the sales volume of sustained-release preparations in 2006-2009 accounted for 14.24%, 20.91% and 21.45% respectively, , 23.03%, also showed a year-on-year rise. Conclusions Calcium channel blockers and angiotensin Ⅱ receptor blockers are the main antihypertensive drugs in our hospital. The variety of drugs is increasing, and the controlled and controlled release formulations are gradually being welcomed in clinical application.